Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 28, 2020; 26(36): 5437-5449
Published online Sep 28, 2020. doi: 10.3748/wjg.v26.i36.5437
Published online Sep 28, 2020. doi: 10.3748/wjg.v26.i36.5437
Table 4 Characteristics of home-based vs infusion centre-based rapid protocol groups
| Variable | Home based rapid infusion group, n (%) | Infusion centre based rapid infusion group, n (%) | P value |
| Total patients/infusions | 32 / 405 | 97/1067 | - |
| Male (%) | 18 (56.2) | 37 (38.1) | 0.10 |
| Age (median, range) | 36 (18, 79) | 42(16, 86) | 0.05 |
| BMI > 30 | 7 (21.9) | 24 (24.7) | 0.82 |
| Smoker | 6 (18.8) | 20 (20.6) | 1.00 |
| Disease type | |||
| CD | 26 (81.2) | 88 (90.7) | 0.20 |
| UC | 6 (18.8) | 8 (8.2) | 0.11 |
| Indeterminate | 0 (0) | 1 (1.0) | 1.00 |
| Extra-intestinal manifestations | 9 (28.1) | 20 (20.6) | 0.46 |
| Psychiatric co-morbidity | 10 (31.2) | 35 (36.1) | 0.67 |
| ADRs (any severity) | 0 (0.0%) | 8 (8.2) | 0.20 |
- Citation: Bohra A, Rizvi QAA, Keung CYY, Vasudevan A, van Langenberg DR. Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability. World J Gastroenterol 2020; 26(36): 5437-5449
- URL: https://www.wjgnet.com/1007-9327/full/v26/i36/5437.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i36.5437